Tuesday, April 04, 2017 1:21:44 PM
Print this page
4/2/2017 6:53:00 PM EDT
Department of Community and Economic Development Secretary Dennis Davin today provided remarks at a ribbon cutting event for Adaptimmune Therapeutics, a clinical stage biopharmaceutical company that committed to the creation of 110 new, full-time jobs through a 2015 project with the Governors Action Team.
Joined by Adaptimmune leadership and employees and representatives from Philadelphia Industrial Development Corporation (PIDC) and Liberty Property Trust, Davin outlined Governor Wolfs 2017-18 budget proposal that encourages job creation, industry growth, and further investment in workforce training.
Its an honor to participate in Adaptimmunes ribbon cutting event today for the companys new headquarters and manufacturing expansion and commitment of 110 new, high-paying, full-time jobs at the Philadelphia Navy Yard, said Sec. Davin. Governor Wolf is committed to providing the resources needed to create new jobs, as well as support and retain existing jobs through workforce training and investment that will continue to grow our economy in every community throughout the state.
The ribbon cutting marks the opening of Adaptimmunes newly constructed, 47,400-square-foot U.S. headquarters and base for clinical and manufacturing operations at the Philadelphia Navy Yard. The company invested more than $4 million in the project and committed to the creation of 110 new, full-time jobs and the retention of 14 existing positions over within three years.
Governor Wolfs 2017-18 budget continues to invest in 21st century manufacturing, workforce development, and training programs while also implementing new safeguards to ensure taxpayer dollars for economic development projects are spent appropriately and intended outcomes are met.
Recent ADAP News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 08:15:42 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 11:23:14 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 11:05:55 AM
- U.S. Futures Steady as Markets Await Key Inflation Data, Oil Prices Climb • IH Market News • 08/12/2024 09:47:41 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 11:00:19 AM
- Adaptimmune Receives U.S. FDA Accelerated Approval of TECELRA® (afamitresgene autoleucel), the First Approved Engineered Cell Therapy for a Solid Tumor • Business Wire • 08/02/2024 12:20:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/16/2024 08:30:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 09:00:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2024 08:15:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 11:39:58 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 11:14:55 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 11:34:32 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 12:05:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 01:13:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:05:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 10:07:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 10:31:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 10:30:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 10:02:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 10:02:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 10:01:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 10:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 10:00:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 10:00:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 12:46:16 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM